Magnetic Blood Purification-based soluble fms-like tyrosine kinase-1 Removal in Comparison with Dextran Sulfate Apheresis and Therapeutic Plasma Exchange.

Thomas RduchNorbert ArnJanis KinkelTina FischerIsabelle BinetRené HornungInge Katrin Herrmann

Published in: Artificial organs (2023)

Taken together, the highly selective removal of sFlt-1 and potential other disease-causing factors by extracorporeal magnetic blood purification may offer new prospects for preeclamptic patients.

Keyphrases

tyrosine kinase
epidermal growth factor receptor
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
molecularly imprinted
prognostic factors
patient reported outcomes
current status